// App-Quantinova.ai

14610 2014 BOS : Anti-miR33 Therapy Promotes PGC1? Expression, Mitochondrial Function and Immunometabolic Pathways in Macrophages in Atherosclerosis

Researchers

Presenter

  • A Brianne Thrush

Principal Investigators

  • Eleni Ramphos

  • Zongbin Wu

  • Michele Geoffrion

  • Christine Esau

  • Kathryn J Moore

  • Mary-Ellen Harper

  • Katey J Rayner

Medical Centers

  • New York Univ Sch of Med, New York, NY

  • University of Ottawa Heart Institute, Ottawa, ON, Canada

  • Univ of Ottawa, Ottawa, Canada

Locations

  • United States

  • Canada

Companies

  • Regulus Therapeutics

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Coronary Artery Disease

  • Tuberculosis

Biomarkers

  • Peroxisome proliferator activated receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved